Wendy McDermott - Feb 28, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
VP, Human Resources
Signature
/s/ Wendy E. McDermott
Stock symbol
LXRX
Transactions as of
Feb 28, 2024
Transactions value $
-$58,754
Form type
4
Date filed
2/29/2024, 04:31 PM
Previous filing
Feb 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +18.9K +66.52% 47.4K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Options Exercise +27.7K +58.41% 75.1K Feb 28, 2024 Direct F1
transaction LXRX Common Stock Tax liability -$58.8K -22.4K -29.85% $2.62 52.7K Feb 28, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -18.9K -50% 18.9K Feb 28, 2024 Common Stock 18.9K Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -27.7K -33.33% 55.4K Feb 28, 2024 Common Stock 27.7K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.